Additional Indications
             journals


Aldehyde metabolism is potentially linked to numerous diseases and conditions. The underlying body of independently derived research suggests a wide range of potential target diseases for ALDH modulators (both activators and inhibitors), including:

  • Orphan indications

    • Cardiovascular diseases such as pulmonary artery disease and ischemic heart damage

      • Inhibition of cancer cell growth

        • Radiation dermatitis

          • Management of neurological disorders such as Parkinson's disease








© 2013 Aldea Pharmaceuticals   |   3696 Haven Avenue, Suite C, Redwood City, CA 94063   |   Tel: 650.241.1600